The news: Keeping people two meters apart from each other is far more effective than just one at reducing the risk of spreading coronavirus, according to a new analysis in The Lancet. The researchers combed through 172 observational studies across 16 countries and then applied statistical analysis to pull out estimates of infection risk. The models they used on nine key studies found that the transmission risk when people stood at least one meter away was an average of around 3%, but rose to about 13% when people were standing within one meter. The risk of transmission roughly halves for every extra meter of distancing up to three meters, the modeling suggested.
Masks, too: The researchers also found that both face coverings and eye protection significantly reduce the risk of spreading the virus: an analysis of the studies found that masks cut the risk of infection from 17% to 3% while eye protection reduces it from 16% to 6%. Other factors such as how long the people had been exposed were not taken into account as they were not part of the original data sets.
Why it matters: Governments around the world are discussing how to ensure people’s safety while lifting lockdown restrictions. It’s clear from this peer-reviewed paper that keeping people as physically apart from each other as possible has to be at the core of any sensible strategy. The findings should also inform workplaces, restaurants, bars, and movie theaters that are currently trying to work out how to get people back through their doors while protecting them from spreading covid-19 to each other.
Differing approaches: Distancing advice varies from country to country. In the UK it’s two meters currently, although there is some pressure to reduce that distance. In the US, the CDC advises six feet (1.8 meters), Australia and Germany say 1.5 meters, and France has one meter as its official guideline. The World Health Organization recommends people stay one meter apart.
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
How AI can help us understand how cells work—and help cure diseases
A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.